Qaiser Bashir

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 19 papers. Top paper: “Decrease post-transplant relapse using donor-derived expanded NK-cells”.

Decrease post-transplant relapse using donor-derived expanded NK-cells

Leukemia(2021)10.1038/s41375-021-01349-4

N/A

2.5DataRank · unranked

104 citations

Piyanuch Kongtim, Doris Soebbing, Prashant Trikha, Gregory K. Behbehani, Gabriela Rondón +15 more

Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation

Journal of Clinical Oncology(2021)10.1200/jco.20.02608

N/A

2.1DataRank · unranked

66 citations

Ruitao Lin, David Marín, Hind Rafei, Mustafa Bdiwi, Peter F. Thall +38 more

Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities

Blood Advances(2023)10.1182/bloodadvances.2023010850

N/A

0.462DataRank · unranked

12 citations

Oren Pasvolsky, Roland L. Bassett, Rohtesh S. Mehta, Amanda Olson, Julianne Chen +21 more

Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome

Blood Advances(2021)10.1182/bloodadvances.2021004865

N/A

0DataRank · unranked

54 citations

Kwang Woo Ahn, Carlos Litovich, Yue Chen, Amer Assal, Qaiser Bashir +25 more

Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1377

N/A

0DataRank · unranked

7 citations

Denái R. Milton, Alison Gulbis, Elias Jabbour, Loretta J. Nastoupil, Celina Ledesma +16 more

The results of multicenter phase II, double-blind placebo-controlled trial of maintenance ixazomib after allogeneic hematopoietic cell transplantation (alloHCT) for high-risk multiple myeloma (MM) from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 1302).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7003

N/A

0DataRank · unranked

2 citations

Qaiser Bashir, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +11 more

Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era

Leukemia(2021)10.1038/s41375-021-01233-1

N/A

0DataRank · unranked

1 citations

Sagar S. Patel, Saulius Girnius, Lohith Bachegowda, Raphael Fraser, Omar Dávila +42 more

A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation

Bone Marrow Transplantation(2022)10.1038/s41409-022-01705-7

N/A

0DataRank · unranked

10 citations

Peter F. Thall, Junsheng Ma, Benigno C. Valdez, Roland L. Bassett, Julianne Chen +20 more

A Multicenter Phase II, Double-Blind, Placebo-Controlled Trial of Maintenance Ixazomib After Allogeneic Transplantation for High-Risk Multiple Myeloma: Results of the Blood and Marrow Transplant Clinical Trials Network 1302 Trial

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.07.007

N/A

0DataRank · unranked

9 citations

T Nishihori, Marcelo C. Pasquini, Michael J. Martens, Juan Wu, Melissa Alsina +15 more

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.05.023

N/A

0DataRank · unranked

5 citations

Leonard C. Alsfeld, Denái R. Milton, Ruby Delgado, Uday Popat, Yago Nieto +21 more

Characteristics and Outcomes of Patients With Multiple Myeloma Who Developed Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome After Autologous Cell Transplantation

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.06.015

N/A

0DataRank · unranked

9 citations

Uri Greenbaum, Oren Pasvolsky, Denái R. Milton, Rashmi Kanagal‐Shamanna, Jeremy Ramdial +15 more

Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplant

Bone Marrow Transplantation(2023)10.1038/s41409-023-02006-3

N/A

0DataRank · unranked

9 citations

Yingjun Wang, Denái R. Milton, Zijun Y. Xu‐Monette, Elias Jabbour, May Daher +13 more

Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.09.013

N/A

0DataRank · unranked

7 citations

Samer A. Srour, Denái R. Milton, Jeremy Ramdial, Neeraj Saini, Amanda Olson +10 more

Patient Characteristics and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Blood(2023)10.1182/blood-2023-181031

N/A

0DataRank · unranked

1 citations

Hina Khan, Denái R. Milton, Oren Pasvolsky, Mark R. Tanner, Uday Popat +18 more

Safety and efficacy of a new high‐dose regimen of panobinostat, gemcitabine, busulfan, and melphalan for 1st or 2nd salvage ASCT for refractory/relapsed or high‐risk myeloma: Matched‐pair comparisons with concurrent control cohorts

American Journal of Hematology(2023)10.1002/ajh.27168

N/A

0DataRank · unranked

0 citations

Zixi Yang, Benigno C. Valdez, Suprateek Kundu, Qaiser Bashir, Jeremy Ramdial +3 more

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

Blood Advances(2020)10.1182/bloodadvances.2019001266

N/A

0DataRank · unranked

36 citations

Rajneesh Nath, Jan Černý, Hai-Lin Wang, Mei-Jie Zhang, Hisham Abdel‐Azim +80 more

Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.06.001

N/A

0DataRank · unranked

8 citations

Curtis Marcoux, Jianliang Dai, Denái R. Milton, Mark R. Tanner, Naureen Syed +18 more

Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cells

Experimental Hematology(2020)10.1016/j.exphem.2020.01.003

N/A

0DataRank · unranked

14 citations

Yang Li, David Murray, Yan Liu, Yago Nieto, Qaiser Bashir +3 more

Significance of minimal residual disease monitoring by real‐time quantitative polymerase chain reaction in core binding factor acute myeloid leukemia for transplantation outcomes

Cancer(2020)10.1002/cncr.32769

N/A

0DataRank · unranked

34 citations

Keyur P. Patel, Qaiser Bashir, David Marín, Sairah Ahmed, Amin M. Alousi +8 more